| Nome |
# |
|
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation, file e2913fdb-7633-f688-e053-3705fe0a67e0
|
400
|
|
Potential applications of nanocellulose-containing materials in the biomedical field, file e2913fdb-ac03-f688-e053-3705fe0a67e0
|
284
|
|
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness, file e2913fdc-3838-f688-e053-3705fe0a67e0
|
269
|
|
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival, file e2913fdd-07af-f688-e053-3705fe0a67e0
|
209
|
|
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases, file e2913fdc-a56a-f688-e053-3705fe0a67e0
|
196
|
|
Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options., file e2913fda-3cb2-f688-e053-3705fe0a67e0
|
181
|
|
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines, file e2913fdb-b728-f688-e053-3705fe0a67e0
|
174
|
|
Mutations in the 3' untranslated region (3' UTR) of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia, file e2913fdb-d4ea-f688-e053-3705fe0a67e0
|
161
|
|
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature, file e2913fdc-5fb1-f688-e053-3705fe0a67e0
|
158
|
|
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies, file e2913fdb-743a-f688-e053-3705fe0a67e0
|
144
|
|
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia, file e2913fdd-13c0-f688-e053-3705fe0a67e0
|
132
|
|
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis, file e2913fdd-7c6a-f688-e053-3705fe0a67e0
|
111
|
|
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components, file e2913fdf-74e3-f688-e053-3705fe0a67e0
|
93
|
|
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects, file e2913fdf-0654-f688-e053-3705fe0a67e0
|
85
|
|
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells, file e2913fdc-da19-f688-e053-3705fe0a67e0
|
84
|
|
SF3B1-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation, file e2913fde-d7a5-f688-e053-3705fe0a67e0
|
84
|
|
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs, file e2913fdf-0656-f688-e053-3705fe0a67e0
|
75
|
|
Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy, file e2913fdf-666f-f688-e053-3705fe0a67e0
|
73
|
|
Mutations in the 3' untranslated region (3' UTR) of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia, file e2913fdb-d3a5-f688-e053-3705fe0a67e0
|
61
|
|
TP53 mutations with low variant allele frequency predict short survival in Chronic Lymphocytic Leukemia, file e2913fde-c86b-f688-e053-3705fe0a67e0
|
55
|
|
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules, file e2913fde-c5c9-f688-e053-3705fe0a67e0
|
48
|
|
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report, file e2913fdc-a9a6-f688-e053-3705fe0a67e0
|
46
|
|
Hepatitis C Virus–Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment, file e2913fdf-8cbd-f688-e053-3705fe0a67e0
|
46
|
|
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia, file e2913fde-507d-f688-e053-3705fe0a67e0
|
35
|
|
DEFB1 polymorphisms and salivary hBD-1 concentration in Oral Lichen Planus patients and healthy subjects, file e2913fdf-27e0-f688-e053-3705fe0a67e0
|
35
|
|
Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration, file e2913fdf-47a0-f688-e053-3705fe0a67e0
|
34
|
|
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response, file e2913fda-cf88-f688-e053-3705fe0a67e0
|
33
|
|
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study, file e2913fdf-b180-f688-e053-3705fe0a67e0
|
28
|
|
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199, file e2913fde-f190-f688-e053-3705fe0a67e0
|
26
|
|
HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia, file e2913fdd-7233-f688-e053-3705fe0a67e0
|
25
|
|
A transient cutaneous relapse of AML M1 in hematological remission: A case report, file e2913fdd-7119-f688-e053-3705fe0a67e0
|
17
|
|
Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration, file e2913fda-51fa-f688-e053-3705fe0a67e0
|
14
|
|
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway, file e2913fdf-b74f-f688-e053-3705fe0a67e0
|
13
|
|
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification, file e2913fdf-8cbc-f688-e053-3705fe0a67e0
|
12
|
|
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response, file e2913fda-73a9-f688-e053-3705fe0a67e0
|
10
|
|
DEFB1 polymorphisms and salivary hBD-1 concentration in Oral Lichen Planus patients and healthy subjects, file e2913fdb-0181-f688-e053-3705fe0a67e0
|
10
|
|
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival, file e2913fdd-1ee9-f688-e053-3705fe0a67e0
|
10
|
|
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles ofTP53disrupted chronic lymphocytic leukaemia cells, file e2913fd9-4d92-f688-e053-3705fe0a67e0
|
8
|
|
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199, file e2913fdb-0321-f688-e053-3705fe0a67e0
|
8
|
|
Hepatitis C virus and non-Hodgkin's lymphoma ten years later, file e2913fd9-f028-f688-e053-3705fe0a67e0
|
7
|
|
Hematologic problems in the Critically III, file e2913fda-ef65-f688-e053-3705fe0a67e0
|
6
|
|
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia., file e2913fdb-51aa-f688-e053-3705fe0a67e0
|
6
|
|
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs, file e2913fdb-5f1a-f688-e053-3705fe0a67e0
|
6
|
|
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects, file e2913fdb-adeb-f688-e053-3705fe0a67e0
|
6
|
|
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components, file e2913fdb-af66-f688-e053-3705fe0a67e0
|
6
|
|
null, file e2913fd8-f598-f688-e053-3705fe0a67e0
|
4
|
|
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application., file e2913fd9-4fb6-f688-e053-3705fe0a67e0
|
4
|
|
Platelet production and destruction in liver cirrhosis, file e2913fda-3120-f688-e053-3705fe0a67e0
|
4
|
|
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response, file e2913fda-7af9-f688-e053-3705fe0a67e0
|
4
|
|
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation, file e2913fdb-8105-f688-e053-3705fe0a67e0
|
4
|
|
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia, file e2913fdc-f2e8-f688-e053-3705fe0a67e0
|
4
|
|
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis, file e2913fdc-f6f5-f688-e053-3705fe0a67e0
|
4
|
|
Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy, file e2913fdd-6448-f688-e053-3705fe0a67e0
|
4
|
|
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study, file e2913fdd-805e-f688-e053-3705fe0a67e0
|
4
|
|
null, file e2913fd9-0431-f688-e053-3705fe0a67e0
|
3
|
|
Efficacy and safety of pegylated interferon plus ribairin for the treatment of hepatitis C virus-positive cryoglobulinemic glomerulonephritis, file e2913fd9-ec10-f688-e053-3705fe0a67e0
|
3
|
|
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells, file e2913fda-3d31-f688-e053-3705fe0a67e0
|
3
|
|
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results., file e2913fdd-32a1-f688-e053-3705fe0a67e0
|
3
|
|
CD49d promotes disease progression in chronic lymphocytic leukemia: New insights from CD49d bimodal expression, file e2913fdd-72c3-f688-e053-3705fe0a67e0
|
3
|
|
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification, file e2913fdd-ae27-f688-e053-3705fe0a67e0
|
3
|
|
null, file e2913fd8-f59a-f688-e053-3705fe0a67e0
|
2
|
|
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles., file e2913fd9-16ee-f688-e053-3705fe0a67e0
|
2
|
|
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia., file e2913fda-3462-f688-e053-3705fe0a67e0
|
2
|
|
Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?, file e2913fda-40a3-f688-e053-3705fe0a67e0
|
2
|
|
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs, file e2913fdb-57fb-f688-e053-3705fe0a67e0
|
2
|
|
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells, file e2913fdb-5870-f688-e053-3705fe0a67e0
|
2
|
|
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells, file e2913fdd-2504-f688-e053-3705fe0a67e0
|
2
|
|
Hepatitis C Virus–Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment, file e2913fdd-5500-f688-e053-3705fe0a67e0
|
2
|
|
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study., file e2913fd9-0a45-f688-e053-3705fe0a67e0
|
1
|
|
Etiologic treatment of hepatitis C virus-associated mixed cryoglobulinemia., file e2913fd9-0ab9-f688-e053-3705fe0a67e0
|
1
|
|
Novel hepatocellular carcinoma molecules with prognostic
and therapeutic potentials, file e2913fd9-19bb-f688-e053-3705fe0a67e0
|
1
|
|
No evidence of Polyomavirus and EBV infections in Italian patients with mixed cryoglobulinemia infected chronically with HCV, file e2913fd9-1c30-f688-e053-3705fe0a67e0
|
1
|
|
null, file e2913fda-33fc-f688-e053-3705fe0a67e0
|
1
|
|
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles, file e2913fda-3e90-f688-e053-3705fe0a67e0
|
1
|
|
null, file e2913fda-46d3-f688-e053-3705fe0a67e0
|
1
|
|
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection, file e2913fdb-017d-f688-e053-3705fe0a67e0
|
1
|
|
Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC, file e2913fdb-01e9-f688-e053-3705fe0a67e0
|
1
|
|
The role of the transcription factor E2F1 in hepatocellular carcinoma, file e2913fdb-54ac-f688-e053-3705fe0a67e0
|
1
|
|
null, file e2913fdb-5910-f688-e053-3705fe0a67e0
|
1
|
|
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells, file e2913fdb-93e7-f688-e053-3705fe0a67e0
|
1
|
|
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components, file e2913fdb-accd-f688-e053-3705fe0a67e0
|
1
|
|
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: Link between the NOTCH1 and the NF-κ B pathways, file e2913fdc-e689-f688-e053-3705fe0a67e0
|
1
|
|
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia, file e2913fdc-f2b5-f688-e053-3705fe0a67e0
|
1
|
|
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis, file e2913fdc-f6f6-f688-e053-3705fe0a67e0
|
1
|
|
NOTCH1 mutational status in chronic lymphocytic leukaemia: Clinical relevance of subclonal mutations and mutation types, file e2913fdd-120f-f688-e053-3705fe0a67e0
|
1
|
|
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia, file e2913fdd-13cc-f688-e053-3705fe0a67e0
|
1
|
|
Direct-acting antiviral agents for hepatitis C virus-mixed cryoglobulinaemia: dissociated virological and haematological responses, file e2913fde-442a-f688-e053-3705fe0a67e0
|
1
|
|
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer, file e2913fde-485a-f688-e053-3705fe0a67e0
|
1
|
|
TP53 mutations with low variant allele frequency predict short survival in Chronic Lymphocytic Leukemia, file e2913fdf-3f6e-f688-e053-3705fe0a67e0
|
1
|
|
TP53 mutations with low variant allele frequency predict short survival in Chronic Lymphocytic Leukemia, file e2913fdf-3f6f-f688-e053-3705fe0a67e0
|
1
|
| Totale |
3.616 |